Results 141 to 150 of about 3,869 (167)

Levosimendan

Drugs of the Future, 2000
null Toller, W.G., null Pagel, P.S., null Kersten, J.R., null Warltier, D.C.   +3 more
openaire   +1 more source

Effects of Levosimendan, a Cardiotonic Agent Targeted to Troponin C, on Cardiac Function and on Phosphorylation and Ca2+Sensitivity of Cardiac Myofibrils and Sarcoplasmic Reticulum in Guinea Pig Heart

Circulation Research, 1995
István Edes, Yoshimi Kitada, Julius Gy Papp   +2 more
exaly  

Efficacy and safety of intravenous levosimendan compared with dobutamine in severe low-output heart failure (the LIDO study): a randomised double-blind trial

Lancet, The, 2002
J G F Cleland
exaly  

Effect of levosimendan and predictors of recovery in patients with peripartum cardiomyopathy, a randomized clinical trial

Clinical Research in Cardiology, 2011
Murat Biteker, Hasan Kaya, Sabahattin Gunduz   +2 more
exaly  

Intravenous Levosimendan vs. Dobutamine in Acute Decompensated Heart Failure Patients on Beta-Blockers

European Journal of Heart Failure, 2010
Claes-Håkan Bergh, Bert Andersson, Kolbjorn Forfang   +2 more
exaly  

Levosimendan Enhances Force Generation of Diaphragm Muscle from Patients with Chronic Obstructive Pulmonary Disease

American Journal of Respiratory and Critical Care Medicine, 2009
Hieronymus W H Van Hees, Leo M A Heunks
exaly  

Levosimendan, a novel Ca2+ sensitizer, activates the glibenclamide-sensitive K+ channel in rat arterial myocytes

European Journal of Pharmacology, 1997
H Yokoshiki, Yasuhiro Katsube, Masanori Sunagawa   +2 more
exaly  

Levosimendan

Der Anaesthesist, 2004
J.-P. Braun, U. D�pfmer, M. Kastrup, I. Roots, A. Borges, M. Schneider, P. Dohmen, W. Kox, C. Spies   +8 more
openaire   +1 more source

Levosimendan induces NO production through p38 MAPK, ERK and Akt in porcine coronary endothelial cells: role for mitochondrial KATPchannel

British Journal of Pharmacology, 2009
Elena Grossini, C Molinari, G Vacca
exaly  

Pharmacokinetics of levosimendan and its circulating metabolites in patients with heart failure after an extended continuous infusion of levosimendan

British Journal of Clinical Pharmacology, 2004
Saila Antila, Matti Kivikko, Lasse Lehtonen   +2 more
exaly